Veradigm Inc. (MDRX) Discusses Strategic Reset, Product Portfolio Decisions and Growth Initiatives February 18, 2026 8:00 AM EST
Company Participants
Jenny Gelinas – Vice President of Investor Relations
Donald Trigg – Chief Executive Officer & Director
Leland Westerfield – Interim Chief Financial Officer
Conference Call Participants
Jeffrey Garro – Stephens Inc., Research Division
George Hill – Deutsche Bank AG, Research Division
Charles Rhyee – TD Cowen, Research Division
Eric Percher – Nephron Research LLC
Presentation
Operator
Greetings, and welcome to the Veradigm Update Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to Jenny Gelinas, Vice President of Investor Relations. Thank you. You may begin.
Jenny Gelinas
Vice President of Investor Relations
Thank you very much. Good morning, and welcome to the Veradigm Update Conference Call. Our speakers today are Don Trigg, Veradigm’s Chief Executive Officer; and Lee Westerfield, our Interim Chief Officer.
We will be making a number of forward-looking statements during the presentation and Q&A part of the call. These statements are based on current expectations, and involve a number of risks and uncertainties that could cause our actual results to vary materially of those reflected in the forward-looking statements. We undertake no obligation to revise these forward-looking statements in light of new information or future events. Please refer to our releases and SEC filings for more information regarding the risk factors that may affect our results. All information presented today is estimated and unaudited.
We will start today’s meeting with remarks from Don, followed by a financial update from Lee. And with that, I’m going to hand the call over to Don.
Donald Trigg
Chief Executive Officer & Director
Thank you, Jenny. Good morning. On my first investor call in October, I committed to advance 3 strategic objectives in my first 100








